EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Implementing use of cystatin C‐guided estimated glomerular filtration rate for medication dosing at an Academic Medical Center

Victoria Williams, Rupal Parbhoo, Bruce Doepker, Claire Murphy, Lynn Wardlow, Kevin Kissling, Megan Bond, Kelly Bartsch, Sree Satyapriya, Markisha Wilder, Jessica Greco, Anthony Gerlach

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2025-05 · 8 (5) · 376-384

DOI: 10.1002/jac5.70035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, online erschienen am 10.04.2025. Verfasst von Victoria Williams und 11 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate kidney function assessment is essential for medication dosing, although traditional methods such as urine output and serum creatinine are limited, especially in patients with acute kidney injury. Cystatin C was made available as an alternative marker at our institution, prompting the formation of a multidisciplinary task force to guide its use and resolve discrepancies in clinical practice using a Plan‐Do‐Study‐Act framework. Plan‐Do‐Study‐Act is a validated approach to developing and evaluating interventions to ensure that changes to a process result in the desired improvement. The task force developed pharmacist‐focused education, creating guidance documents and asynchronous training with competency assessments. An audit revealed that cystatin C was primarily used in intensive care units for dosing antibiotics like cefepime and vancomycin. In response, updates to clinical decision support systems in electronic medical records were made. A progress note template was designed and implemented to communicate cystatin C assessments and dosing changes based on this kidney filtration marker. Ongoing quality improvement efforts are focusing on broadening education, refining documentation, and researching optimal cystatin C use.

Zitieren

APA

Williams, V., Parbhoo, R., Doepker, B., Murphy, C., Wardlow, L., Kissling, K., Bond, M., Bartsch, K., Satyapriya, S., Wilder, M., Greco, J., & Gerlach, A. (2025). Implementing use of cystatin C‐guided estimated glomerular filtration rate for medication dosing at an Academic Medical Center. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 8(5), 376-384. https://doi.org/10.1002/jac5.70035

Vancouver

Williams V, Parbhoo R, Doepker B, Murphy C, Wardlow L, Kissling K, et al. Implementing use of cystatin C‐guided estimated glomerular filtration rate for medication dosing at an Academic Medical Center. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2025;8(5):376-384. doi:10.1002/jac5.70035

BibTeX
@article{Williams2025,
  author = {Williams, Victoria and Parbhoo, Rupal and Doepker, Bruce and Murphy, Claire and Wardlow, Lynn and Kissling, Kevin and Bond, Megan and Bartsch, Kelly and Satyapriya, Sree and Wilder, Markisha and Greco, Jessica and Gerlach, Anthony},
  title = {Implementing use of cystatin C‐guided estimated glomerular filtration rate for medication dosing at an Academic Medical Center},
  journal = {JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY},
  year = {2025},
  volume = {8},
  number = {5},
  pages = {376--384},
  doi = {10.1002/jac5.70035}
}
Kostenlos starten →